2026-01-22 05:28:36

A major investment bank has raised its price target for Structure Therapeutics Inc to $105, significantly up from the previous $65 level. This represents a substantial 61% upside potential, reflecting the bank's increased confidence in the biotech firm's prospects. The upgrade highlights how traditional finance institutions are reshuffling their sector allocations—a signal worth tracking for those monitoring broader market sentiment shifts across different asset classes.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

17 Likes

Reward
17
9
Repost
Share

Comment

0/400

HodlVeteran

· 01-25 05:00

From 65 to 105, isn't this a classic "cut first, then lift" routine... I've seen too many experienced traders fall for it Wait, is Wall Street now starting to bet on biotech? Should I cash out of that altcoin I previously went all-in on? A 61% profit bait, sounds just like the promises before the P2P爆雷... But STRUCTURE does have some real stuff, though the take-over fee is too high, bro Traditional finance is starting to turn, is this a sign that the bear market is ending? Or another round of retail investor slaughter? I bet five bucks the next correction will still cut deep The biotech pharmaceutical trap, if you don't understand the underlying logic, stay away—blood loss is inevitable Wall Street's attitude has shifted, and retail investors' fate as cannon fodder is sealed [dog head emoji]

View OriginalReply0

RugpullSurvivor

· 01-24 22:08

Damn, from 65 to 105? Did this bank see some shady stuff or have they really changed their tune...

View OriginalReply0

CompoundPersonality

· 01-22 05:58

Speaking of this 61% increase... it sounds impressive, but I need to see the signals from traditional financial institutions adjusting their positions... Is this really the wave for biotech?

View OriginalReply0

just_another_fish

· 01-22 05:58

Wow, with this increase, traditional finance is starting to bet on biomedicine?

View OriginalReply0

LiquidationOracle

· 01-22 05:57

Hmm... from 65 to 105? Such a huge increase, traditional finance is starting to hype up biotech again, same old tricks.

View OriginalReply0

LiquidityHunter

· 01-22 05:53

Wait, this increase from $65 to $105... 61%? Recalculate to see if there's slippage room, will institutional investors' rebalancing cause a dump, and how is the liquidity depth?

View OriginalReply0

GateUser-40edb63b

· 01-22 05:48

A 61% increase expectation... If banks dare to call it like that, there must be something behind it. However, biotech is a bit of a hot potato.

View OriginalReply0

AlphaWhisperer

· 01-22 05:44

Wait, from 65 to 105? This increase... Are we about to see another institutional play to trap retail investors? Haha

View OriginalReply0

ChainProspector

· 01-22 05:36

Wait, from 65 to 105? That's an incredible surge... Are traditional financial institutions starting to shift positions into biotech? Need to keep an eye on this.

View OriginalReply0